CDK6 and colitis: Besides driving the transcription of tumor-promoting genes such as c-Myc and cyclin-dependent kinase-6 (CDK6), a previous study explored a critical oncogenic role of NFATc2 in colitis-induced colon cancer by control of proinflammatory cytokine IL-6 production39.